ResourceDrug Discovery & Development
High-throughput chemoproteomic profiling of ligandable cysteine sites with CysScout
18 Jun 2026This scientific poster presents CysScout™, a high-throughput chemoproteomic platform developed by Momentum Biotechnologies for the global identification of ligandable cysteine sites in complex proteomes. Covalent therapeutics target reactive amino acids such as cysteine, and this platform enables systematic screening of small molecules and fragment libraries to uncover druggable protein sites.
Resource details:
- Resource type: Scientific poster
- Page count: 1
- Read time: 2 mins
Links
Tags
ProteomicsProteomics is the systemic bioinformatics study of proteins and amino acids, including their structure, size, function and identification. Tools used in proteomics include chromatography, blotting and gels, protein arrays, mass spectrometry and ELISA and associated analysis software. Analyzers and proteomic systems should be sensitive, high resolution, fast and may be automated for high-throughput.LC-MS / MSDrug DiscoveryDrug discovery is the process of identifying potential new medications, involving stages such as target identification, compound screening, and preclinical development. It relies on cutting-edge technologies like high-throughput screening, artificial intelligence, and molecular modeling to accelerate the identification of drug candidates. Drug discovery plays a pivotal role in developing new therapies for diseases ranging from cancer to rare genetic disorders. Browse our peer-reviewed product directory to find the latest drug discovery technologies, compare options, check customer feedback, and get pricing directly from manufacturers.